BioRegenerative Sciences Inc., a privately owned stem cell therapeutics corporation headquartered in Carmel Valley, announced recently that Dr. Greg Maguire, CEO and co-founder, has been invited to present a lecture, “Therapeutic and Medical Procedure Development Using Stem Cell-Based S2RM TechnologyTM,” at the international congress titled “Nano and Regenerative Medicines — Opportunities and Challenges for India.” The congress is sponsored by MIT and will be held in Mumbai, India, Dec. 12-13.
President and co-founder Peter Friedman explained that “S2RM TechnologyTM uses the molecules released from multiple stem cell types in a patented process to develop therapeutics and medical procedures that mimic mother nature’s healing processes. When the body is diseased or traumatized, multiple stem cell types are usually recruited to the affected area where the stem cells release a combination of molecules to orchestrate the healing process.”
Maguire added, “ S2RM TechnologyTM has been shown to rebuild tissue, reduce pain and inflammation, and modulate immune function. Using the correct combinations of stem cells, stimulating the cells in different ways, and adjusting the ratios of molecules, we can produce specific types of the S2RM to treat different diseases or traumatic conditions.”
For more information, please email: firstname.lastname@example.org, or call customer service at 877-892-9991.